This Week's News In Infectious Disease

News
Article

This week: the FDA accepts NDA for investigational antibiotic; mRNA COVID-19 vaccines update protections; counseling families on nirsevimab; and how antibiotic actions on gut microbes of patients might affect the microbiome of housemates.

Recent Videos
A panel of 5 experts on C. difficile infections
A panel of 5 experts on C. difficile infections
A panel of 5 experts on C. difficile infections
A panel of 5 experts on C. difficile infections
A panel of 5 experts on C. difficile infections
A panel of 5 experts on C. difficile infections
A panel of 5 experts on C. difficile infections
A panel of 5 experts on C. difficile infections
Related Content
Investigational, Non-Antibiotic Begins Phase 2 Trial for Recurrent C difficile

Investigational, Non-Antibiotic Begins Phase 2 Trial for Recurrent C difficile

Contagion Editorial Team
October 28th 2024
Article
C difficile, Antimicrobials, and the Patients Most Affected

C difficile, Antimicrobials, and the Patients Most Affected

Nina Cosdon
November 23rd 2022
Podcast
Top 5 Infectious Disease News Stories Week Of October 18-25

Top 5 Infectious Disease News Stories Week Of October 18-25

Contagion Editorial Team
October 26th 2024
Article
A Clinician’s Perspective on Rebyota for Recurrent C Diff Treatment

A Clinician’s Perspective on Rebyota for Recurrent C Diff Treatment

John Parkinson;Timothy Ritter, MD
October 23rd 2024
Article
Real World Study of Recurrent Clostridioides difficile Therapy Demonstrates Efficacy, Safety

Real World Study of Recurrent Clostridioides difficile Therapy Demonstrates Efficacy, Safety

John Parkinson
October 16th 2024
Article
New Insights into Clostridioides difficile Infection and Vaccine Development

New Insights into Clostridioides difficile Infection and Vaccine Development

Sophia Abene
October 14th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.